Edition:
United States

OncoGenex Pharmaceuticals Inc (OGXI.OQ)

OGXI.OQ on NASDAQ Stock Exchange Capital Market

0.35USD
24 Apr 2017
Change (% chg)

$-0.02 (-4.18%)
Prev Close
$0.37
Open
$0.36
Day's High
$0.36
Day's Low
$0.35
Volume
66,569
Avg. Vol
86,404
52-wk High
$1.41
52-wk Low
$0.33

Select another date:

Wed, Mar 1 2017

BRIEF-Oncogenex Pharma and Achieve Life Science announce strategic collaboration with National Institutes of Health

* Oncogenex Pharma says Achieve Life Science and co announce strategic collaboration with National Institutes of Health to advance development of cytisine

BRIEF-Oncogenex Pharma believes cash, cash equivalents, short-term investments to be sufficient to fund currently planned operations for next 12 months

* Oncogenex pharma - believes cash, cash equivalents, short-term investments to be sufficient to fund currently planned operations for at least next 12 months

BRIEF-Oncogenex Pharmaceuticals says committed to further reduction in workforce

* Will eliminate 5 positions and estimates that will incur about $750,000 in cash expenditures as a result

BRIEF-Oncogenex Pharmaceuticals reports Q3 loss per share $0.12

* Oncogenex Pharmaceuticals Inc reports financial results for third quarter 2016

BRIEF-Oncogenex says will cut about 55 pct of company's workforce

* Oncogenex - on October 25, 2016, committed to a restructuring of a portion of company's workforce

BRIEF-OncoGenex announces positive survival results from apatorsen Phase 2 trial in metatstatic bladder cancer

* OncoGenex announces positive survival results from apatorsen Phase 2 Borealis-2 trial in metastatic bladder cancer

Select another date:

More From Around the Web